Song, Erfei
27  results:
Search for persons X
?
1

Identification and multicentric validation of soluble CDCP1..:

Jia, Xi ; Song, Erfei ; Liu, Yan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694619/.  , 2023
 
?
2

Hepatic MDM2 causes metabolic associated fatty liver diseas..:

Lin, Huige ; Wang, Lin ; Liu, Zhuohao...
Lin , H , Wang , L , Liu , Z , Long , K , Kong , M , Ye , D , Chen , X , Wang , K , Wu , K K L , Fan , M , Song , E , Wang , C , Hoo , R L C , Hui , X , Hallenborg , P , Piao , H , Xu , A & Cheng , K K Y 2022 , ' Hepatic MDM2 causes metabolic associated fatty liver disease by blocking triglyceride-VLDL secretion via ApoB degradation ' , Advanced Science , vol. 9 , no. 20 , e2200742 . https://doi.org/10.1002/advs.202200742.  , 2022
 
?
3

Caloric restriction-mimetics for the reduction of heart fai..:

Pang, Lei ; Jiang, Xi ; Lian, Xin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252041/.  , 2022
 
?
4

Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatt..:

Qiu, Han ; Song, Erfei ; Hu, Yue...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490100/.  , 2022
 
?
5

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Diseas..:

Lin, Huige ; Wang, Lin ; Liu, Zhuohao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284139/.  , 2022
 
?
6

Deficiency of telomere-associated repressor activator prote..:

Cai, Yin ; Liu, Hao ; Song, Erfei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978321/.  , 2021
 
?
 
?
11

Iron induces insulin resistance in cardiomyocytes via regul..:

Sweeney, Gary ; Sung, Hye Kyoung ; Song, Erfei..
Sung, H.K., Song, E., Jahng, J.W.S. et al. Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress. Sci Rep 9, 4668 (2019)..  , 2019
 
?
 
?
15

Measuring non-polyaminated lipocalin-2 for cardiometabolic ..:

Yang, Kangmin ; Deng, Han-Bing ; Man, Andy W C...
Yang , K , Deng , H-B , Man , A W C , Song , E , Zhang , J , Luo , C , Cheung , B M Y , Yuen , K-Y , Jensen , P S , Irmukhamedov , A , Elie , A , Vanhoutte , P M , Xu , A , De Mey , J G R & Wang , Y 2017 , ' Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment ' , E S C Heart Failure , vol. 4 , no. 4 , pp. 563–575 . https://doi.org/10.1002/ehf2.12183.  , 2017
 
1-15